Stocktwits on MSN

SLS stock breaches $5 level after over 3 years: Retail now eyes buyout for as much as $25B

SELLAS is currently evaluating Galinpepimut-S (GPS) as a potential maintenance therapy in patients with Acute Myeloid ...
Targeted Oncology

Key Takeaways From Long-Term Follow-Up of Early CAR T in LBCL

During a live event, Matthew Lunning, DO, interpreted long-term outcomes of the ZUMA-7 and TRANSFORM trials.
BioTechniques

Single-donor “lung-on-chip” breathes new life into disease modeling and personalized medicine

Lung-on-chip model made of cells derived from a single person furthers understanding of tuberculosis and potential ...